TCHP and cancer: The tumor suppressor protein, p53, mutated in about 50% of human cancers64 was reported to play a key role in cancer cells resistance to certain anticancer drugs and thus considered as a potential cancer-specific target for pharmacologic interventions in human cancers65, 66.